Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
BMhXacUwqwX34GKz
